OSAM
SRNE

O'Shaughnessy Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

O'Shaughnessy Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-6,115
Closed -$47K – 2708
2021
Q3 		$47K Sell
6,115
-4,786
-44% -$40.6K ﹤0.01% 1673
2021
Q2 		$106K Hold
10,901
– – ﹤0.01% 1284
2021
Q1 		$90K Buy
10,901
+9,737
+837% +$103K ﹤0.01% 1239
2020
Q4 		$8K Buy
+1,164
New +$9.35K ﹤0.01% 1601

Other funds holding SRNE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

O'Shaughnessy Asset Management's SRNE Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2021, closing a stake of 6,115 shares — an estimated $47K sold.

O'Shaughnessy Asset Management first reported a position in SRNE in Q4 2020 and held it in 4 quarters. The position peaked at $106K in Q2 2021. 234 funds tracked by Wall St. Rank hold SRNE as of Q4 2021.

  • O'Shaughnessy Asset Management reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 6,115 Sorrento Therapeutics, Inc. shares in Q4 2021, an estimated $47K.
  • O'Shaughnessy Asset Management first reported a position in Sorrento Therapeutics, Inc. in Q4 2020 and held it in 4 quarters.
  • O'Shaughnessy Asset Management's Sorrento Therapeutics, Inc. position peaked at $106K in Q2 2021.
  • 234 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.